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A B S T R A C T
The aim of clinical guidelines is to improve quality of care
by translating new research findings into practice. There
is evidence that the following characteristics contribute to
their use: inclusion of specific recommendations, sufficient
supporting evidence, a clear structure and an attractive
lay out. In the process of formulating recommendations,
implicit norms of the target users should be taken into
account. Guidelines should be developed within a struc-
tured and coordinated programme by a credible central
organisation. To promote their implementation, guidelines
could be used as a template for local protocols, clinical
pathways and interprofessional agreements.
I N T R O D U C T I O N
In this number of the journal, Jacobs et al. describe the
use of a local clinical guideline on haemochromatosis.1
They found the adherence of care providers to key 
recommendations insufficient and even consider certain
elements of care provision undesirable. Naturally they
asked themselves why this guideline failed to reach its goal.
The aim of clinical guidelines is to improve patient care
by providing recommendations about appropriate health-
care in specific clinical circumstances.2 They should be
based on the best evidence available, supplemented with
clinical expertise and patient preferences. Guidelines are
primarily developed to support care providers and
patients, but may also be used by medical insurers in
contracts and by governmental agencies in rationing
healthcare policy.3
Guidelines are only one option for improving quality.
They are especially useful in situations with uncertainty
about appropriate practice, when evidence provides an
answer.4 In other situations integrated care pathways or
the redesign of care processes may be more suitable.
While guidelines can improve the quality of patient care,
we will discuss how, and which limitations occur.5
B E N E F I T S
Clinical guidelines may improve patient care by providing
easily accessible information regarding optimal care. They
summarise research findings and make clinical decisions
more transparent. By showing gaps in current knowledge,
research activities can be prioritised. Ideally, the potential
cost implications of applying the recommendations are
discussed. Thereby they can increase the efficiency of
care and in case of inappropriate use, reduce costs.6
By summarising the benefits and limitations of procedures
and interventions, they contribute to patient safety. To
empower patients, lay versions should inform patients
about optimal care.7 As clinical guideline development
includes a systematic review of the recent scientific 
literature, an up-to-date guideline offers a sound basis for
education. In contrast, textbooks contain material that is
too general and often out of date.8,9 As many guidelines
cover topics that involve different disciplines they provide
a foundation for multiprofessional agreements and col-
laboration.
Guidelines can be used as a reference for professional
audit to evaluate the quality of care.
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L I M I T A T I O N S
If guidelines are applied inappropriately as in ‘cookbook
medicine’, they may lead to misuse. 
As a hypothetical standard patient is usually taken as a
point of reference, the unique clinical presentation could
be neglected. By doing so guidelines oversimplify complex
clinical practice.10 Inexperienced users could be encouraged
to apply recommendations unthinkingly, even in situations
in which departure from the recommendations is desirable.11
Guidelines are produced on the basis of studies in selected
populations in research settings. As a consequence their
results often can not be reproduced in daily practice.12
Because the development of a national guideline demands
large resources,13 their cost-effectiveness is sometimes
questioned, despite positive examples.14 In general, pro-
fessionals strive for autonomy, which is threatened by the
need to follow guidelines.15 Accordingly, professionals
fear an increase in their medico-legal exposure.11
D E V E L O P M E N T  O F  G U I D E L I N E S
The implementation should be considered part of the
development process. Selection of topics, composition of
the guideline group, the work plan, search for evidence
and involvement of clinical experts are all important in this.
On the national level a representative and respected group
of experts from relevant professional organisations reaches
agreement on an area of healthcare. Consensus takes place
on the basis of a systematic review and structured con-
sensus. If there are marked differences between settings,
translation to the local situation is mandatory. Following
the instructive process with the focus on relevant local
conditions is a major advantage for acceptance. A dis-
advantage is the time investment and the suboptimal
results if a systematic review has not been performed.16
Topic selection
Of importance is the topic selection. The more relevant
the topic for resolving the problems encountered, the
more likely the guideline will be accepted. Some problems
cannot be resolved by introducing guidelines,17,18 as for
example shortage or incorrect use of resources, malpractice
resulting from inefficient procedures or topics related to
patient preferences. Appropriate topics can be selected by
the relevance and prevalence of the problem, controversy
about optimal care, existence of proven solutions, barriers
expected when implementing improvements and motivation
and improvement skills of the care providers involved. 
Besides scientific also psychosocial, ethical, legal and
financial aspects play a role in implementing guidelines.
A systematic analysis prior to guideline development
contributes to its successful application.19
Composition of the guideline group
Developing credible clinical guidelines requires a balanced
working group including clinical and methodological
expertise to promote broad consensus and to prevent
bias from conflicts of interests.19 It should also include
representatives of patient groups.17 Adequate staff support
is needed to perform literature searches and a cost-effec-
tiveness analysis.20 A neutral chairman and formal group
processes should be used to achieve consensus.
Work plan 
Next, a work plan is formulated that describes the aims of
the guideline, healthcare problems and settings covered,
desired outcomes (mortality, morbidity, complications,
hospital admissions, quality of life), target group involved
(care providers and patient population), time schedule
and division of the tasks.
Reviewing evidence
The literature search starts by identifying and reviewing
existing guidelines and a systematic literature review,
searching for scientific evidence, an assessment of its
relevance and quality, and the involvement of clinical
experts to formulate and prioritise recommendations.
Guidelines on the same topic can be identified by
searching the US National Guideline Clearinghouse
(www.guideline.gov) and the resources of the Guidelines
International Network (www.g-i-n.net). These databases
together contain more than 2000 guidelines. To assess the
quality of the guideline the ‘Appraisal – Instrument for
Guidelines Research and Evaluation’ (AGREE) instrument
can be used.21 Its purpose is to provide a systematic
framework for assessing key components of guideline
quality including the process of development and
reporting. The items cover the methodology as well as
the clarity and applicability of the guideline. 
Studies are best identified by systematic review. To identify
high-quality systematic reviews the Cochrane Library with
quarterly updates is an excellent source. If no existing
review can be found a range of electronic databases
(Medline, Cinahl, Embase, PubMed) should be searched.
Further relevant individual studies are identified by asking
experts and by hand-searching journals, reference lists of
articles and abstract books. The relevance of the studies
for the questions and patient group involved is evaluated
on the basis of the abstract.22 The next step is to evaluate
the scientific strength of the published research.23
Information about the advantages, disadvantages and
costs of the studied interventions is examined. The evi-
dence is categorised using predefined grading schemes
for preventive, diagnostic, and therapeutic procedures. 
In table 1 such a grading system is shown, as developed
by the Dutch Institute for Quality Improvement in
Healthcare (CBO).
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Involvement of clinical experts
Clinical experts should be involved because in almost
half the clinical decisions there is no good scientific
background.24 When developing a clinical guideline for
angina pectoris, only 21% of the recommendations could
be based on randomised studies.25 Even when there is
consistent evidence for a given clinical practice, the
optimal method of proceeding is seldom immediately
clear. If evidence is found for certain care interventions,
it is often necessary to determine whether the results can
be extrapolated to other patient populations.
On the other hand, the use of experts causes problems.
Some dominate the discussion with their individual
preferences. By structuring the discussions, such prob-
lems can be avoided.26
If no evidence can be found an interview of experienced
care providers can be performed as in the Rand-modified
Delphi Procedure to quantitate ‘expert opinion’.27 A panel of
experts judges the appropriateness of different treatments
in a number of characteristic patients. The judgement of
the appropriateness is determined by considering the
advantages (effectiveness, rapidity and duration of the
response) and disadvantages (invasiveness, side effects,
complications) which are scored. 
F O R M U L A T I O N  O F  R E C O M M E N D A T I O N S
In formulating recommendations the scientific evidence
and clinical expertise are brought together. The following
issues should be considered to ensure implementation:
• Nature and strength of the scientific evidence; the 
balance between the advantages of a given intervention
and its disadvantages.
• Generalisability and applicability to the target population.
• Cost-effectiveness of the proposed intervention.
• Achievability of the intervention in terms of required
skills, instruments, time, available staff, patient’s
preferences and legal or financial limitations.
• Opinions, norms and values, and ethical considerations
of the target users.
With a view to implementation, a work group cannot
avoid the problem as to whether the healthcare system
can afford the innovation. If a guideline recommends
that a patient with a myocardial infarction must receive
thrombolysis within 30 minutes of arrival at the hospital,
then the entire care process must be directed to that aim.
In the interpretation of evidence by experts, normative
and cultural opinions about the desired health benefit
and the acceptable risks play a role. An analysis of guide-
lines for breast cancer revealed that in the USA regular
breast self-examination is advised, while the French point
to the insecurity that this can evoke.28
Levels of evidence 
By including the level of evidence for each recommend-
ation, the work group emphasises the degree to which
application of the recommendations will lead to the
intended results.29 The addition of the results of reviews
and the level of evidence creates a sense of thrust 
worthiness and makes the recommendations transparent,
with a positive influence on the application in practice. 
Ideally, all recommendations are formulated using a
democratic voting procedure in which all relevant infor-
mation (evidence, costs, preferences, organisational
impact) has been considered. 
An external review by a sample of concerned individuals
(experts, patients, managers, insurers) should be part of
the development process.
Promoting acceptability
To promote support, the draft has to be presented at an
open meeting allowing the audience to express their
comments and suggestions. If no consensus is reached, a
voting system can be used. 
To facilitate its applicability in daily care the guideline is
piloted in practice. The results of the pilot and the con-
sultation process are incorporated. Finally, the clinical
guideline can be submitted for approval to an independent
scientific council and to the professional organisations
responsible.30
F O R M A T  O F  T H E  G U I D E L I N E
The next step is designing an accessible and attractive
format. Diagrams and algorithms may clarify the logic in
the decision-making.31 A summary of key recommendations
provides a quick insight. 
Clinical guidelines should be published in professional
journals and posted to every possible user. 
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Table 1 Classification of the literature according to the
strength of the evidence (CBO 2000)
For articles concerning intervention (prevention or therapy)
A1 Systematic reviews of at least a few studies on the A2 level,
of which the results of independent research studies are
consistent
A2 Randomised comparative clinical research of good quality
(randomised, double-blind, controlled trial of adequate
scope and consistency)
B Randomised clinical trials of moderate quality or insuffi-
cient scope, or other comparative research (nonran-
domised, cohort studies, patient-control studies)
C Noncomparative research
D Opinions of experts, such as the work group members
Electronic versions of the guideline and tools for application
(e.g. patient leaflets, educational material, a practice sum-
mary on a plastic-laminated card) have to be developed.32
For audit and performance review the guideline should
include a set of clinical indicators.
E V A L U A T I O N  O F  T H E  G U I D E L I N E
The final step is the overall process of the evaluation of
their application, their applicability and their effects.
Relevant elements are:
• How well is the guideline known and applied? Are the
recommendations understood and remembered? Are
they used in quality improvement activities? If not,
which are not and why? 
• To what extent are they effective? Does their application
lead to the objectives envisioned (better health, lower
costs, better quality of life and more satisfied
patients)?
U P D A T I N G  G U I D E L I N E S
Clinical guidelines require updating if the majority of
recommendations are out-of-date due to changes in
research findings and new available diagnostic or therapeutic
interventions. In general, guidelines should be reassessed
for validity every three years.33 In rapidly evolving fields, for
example AIDS or colonic cancer, yearly review is necessary. 
G U I D E L I N E  Q U A L I T Y
High-quality guidelines can improve healthcare, but
low-quality guidelines may harm patients.5,8 The explosion
of published guidelines may confront physicians with
multiple conflicting guidelines on the same clinical sub-
jects.34 Many are of poor quality. Grilli et al. evaluated 431
guidelines developed by medical specialists. Only 5% met
high-quality criteria and 54% did not meet any.35 Recently
an international appraisal instrument to assess guideline
quality has been developed and validated: the AGREE
instrument (see www.agree.collaboration.org. for
details).21
C O N C L U S I O N
To successfully introduce clinical guidelines, their devel-
opment should consider the implementation from the
very beginning.36 This includes attention to the relevance
of the topic, credibility (systematic development by rigor-
ous transparent methodology), involvement of all relevant
stakeholders and attention to the impact on resources,
materials and facilities, accessibility and an attractive design
and tools for application and monitoring in practice. 
To integrate guidelines into normal care processes they
should be incorporated in local care protocols, disease
management programmes and clinical pathways.
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